Toward an endgame: Finding and engaging people unaware of their HIV-1 infection in treatment and prevention

AIDS Research and Human Retroviruses

Volumn 30, Issue 3, 2014, Pages 217-224

  Burns, David N ^a   DeGruttola, Victor ^b   Pilcher, Christopher D ^c   Kretzschmar, Mirjam ^d,h   Gordon, Christopher M ^e   Flanagan, Elizabeth H ^a   Duncombe, Christopher ^f   Cohen, Myron S ^g  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^e NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^f BILL AND MELINDA GATES FOUNDATION   (United States)

^g UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANAL INTERCOURSE; AWARENESS; BASIC REPRODUCTION NUMBER; COMMUNITY CARE; CONFERENCE PAPER; DRUG USE; GENDER IDENTITY; GENE SEQUENCE; HETEROSEXUAL MALE; HETEROSEXUALITY; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MATHEMATICAL MODEL; MEDICAL INFORMATION SYSTEM; MEN WHO HAVE SEX WITH MEN; PHYLOGENY; PRIMARY INFECTION; PRIORITY JOURNAL; RISK REDUCTION; SEXUAL HEALTH; SEXUALITY; VIRUS ENTRY; VIRUS LOAD; VIRUS TRANSMISSION;

ANTI-HIV AGENTS; DISEASE TRANSMISSION, INFECTIOUS; HEALTH SERVICES NEEDS AND DEMAND; HIV INFECTIONS; HUMANS;

EID: 84895560018     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2013.0274     Document Type: Conference Paper

References (89)

1. Schwarcz L, Chen M-J, Vittinghoff E, et al.: Declining incidence of AIDS-defining opportunistic illnesses: Results from 16 years of population-based AIDS surveillance. AIDS 2013;27(4):597-605.
2. UNAIDS: World AIDS Day Report 2012. www.unaids.org/en/media/unaids/ contentassets/documents/epidemiology/2012/gr2012/JC2434-WorldAIDSday-results-en. pdf. Accessed July 15, 2013.
3. Walensky RP, Paltiel AD, Losina E, et al.: The survival benefits of AIDS treatment in the United States. J Infect Dis 2006;194(1):11-19.
4. Eaton JW, Johnson LF, Salomon JA, et al.: HIV treatment as prevention: Systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa. PLoS Med 2012;9:e1001245.
5. Tanser F, Baernighausen T, Grapsa E, et al.: High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa. Science 2013; 339(6122):966-971.
6. Boily MC, Masse B, Alsallaq R, et al.: HIV treatment as prevention: Considerations in the design, conduct, and analysis of cluster randomized controlled trials of combination HIV prevention. PLoS Med 2012;9(7):e1001250.
7. Sullivan PS, Hamouda O, Delpech V, et al.: Reemergence of the HIV epidemic among men who have sex with men in North America, Western Europe, and Australia, 1996-2005. Ann Epidemiol 2009;19(6):423-431.
8. Bezemer D, de Wolf F, Boerlijst MC, et al.: A resurgent HIV-1 epidemic among men who have sex with men in the era of potent antiretroviral therapy. AIDS 2008;22(9): 1071-1077.
9. Phillips AN, Cambiano V, Nakagawa F, et al.: Increased HIV incidence in men who have sex with men despite high levels of ART-induced viral suppression: Analysis of an extensively documented epidemic. PLoS One 2013;8(2): e55312.
10. Hamers FF and Phillips AN: Diagnosed and undiagnosed HIV-infected populations in Europe. HIV Med 2008;9(Suppl 2):6-12.
11. Chen M, Rhodes PH, Hall IH, et al.: Prevalence of undiagnosed HIV infection among persons aged ≥ 13 years-National HIV Surveillance System, United States, 2005-2008. MMWR Morb Mortal Wkly Rep 2012;61(Suppl): 57-64.
12. Anand A, Shiraishi RW, Bunnell RE, et al.: Knowledge of HIV status, sexual risk behaviors and contraceptive need among people living with HIV in Kenya and Malawi. AIDS 2009;23(12):1565-1573.
13. UNAIDS: World AIDS Day Report 2011. www.unaids.org/en/media/unaids/ contentassets/documents/unaidspublication/2011/jc2216-worldaidsday-report-2011- en.pdf. Accessed June 6, 2013.
14. Cherutich P, Bunnell R, and Mermin J: HIV testing: Current practice and future directions. Curr HIV/AIDS Rep 2013;10(2):134-141.
15. Gouws E and Cuchi P: Focusing the HIV response through estimating the major modes of HIV transmission: A multicountry analysis. Sex Transm Infect 2013;88(Suppl 2):i76- i85.
16. Hall HI, Holtgrave DR, and Maulsby C: HIV transmission rates from persons living with HIV who are aware and unaware of their infection. AIDS 2012;26(7):893-896.
17. Marks G, Crepaz N, and Janssen RS: Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS 2006; 20(10):1447-1450.
18. Wawer MJ, Gray RH, Sewankambo NK, et al.: Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis 2005;191(9):1403-1409.
19. Pilcher CD, Joaki G, Hoffman IF, et al.: Amplified transmission of HIV-1: Comparison of HIV-1 concentrations in semen and blood during acute and chronic infection. AIDS 2007;21(13):1723-1730.
20. Powers KA, Ghani AC, Miller WC, et al.: The role of acute and early HIV infection in the spread of HIV and implications for transmission prevention strategies in Lilongwe, Malawi: A modelling study. Lancet 2011;378(9787):256- 268.
21. Ma Z-M, Keele BF, Qureshi H, et al.: SIVmac251 Is inefficiently transmitted to rhesus macaques by penile inoculation with a single SIVenv variant found in ramp-up phase plasma. AIDS Res Hum Retroviruses 2011;27(12): 1259-1269.
22. Kim JH and Koopman JS: HIV transmissions by stage in dynamic sexual partnerships. J Theor Biol 2012;298:147-153.
23. Alam SJ, Zhang X, Romero-Severson EO, et al.: Detectable signals of episodic risk effects on acute HIV transmission: Strategies for analyzing transmission systems using genetic data. Epidemics 2013;5(1):44-55.
24. Erbelding EJ, Chung SE, Kamb ML, et al.: New sexually transmitted diseases in HIV-infected patients: Markers for ongoing HIV transmission behavior. J Acquir Immune Defic Syndr 2003;33:247-252.
25. Kalichman SC, Pellowski J, and Turner C: Prevalence of sexually transmitted co-infections in people living with HIV/AIDS: Systematic review with implications for using HIV treatments for prevention. Sex Transm Infect 2011;87: 183-190.
26. Pathela P, Braunstein S, Shepard C, et al.: Populationbased HIV incidence among men diagnosed with infectious syphilis, 2000-2011. Paper presented at the 20th Meeting of the International Society for Sexually Transmitted Diseases Research, July 14-17, 2013, Vienna, Austria.
27. Cohen MS, Shaw GM, McMichael AJ, et al.: Acute HIV-1 infection. N Engl J Med 2011;364:1943-1954.
28. Cohen MS, Dye C, Fraser C, et al.: HIV treatment as prevention: Debate and commentary-will early infection compromise treatment-as-prevention strategies? PLoS Med 2012;9:e1001232.
29. Birrell PJ, Gill ON, Delpech VC, et al.: HIV incidence in men who have sex with men in England and Wales 2001-2010: A nationwide population study. Lancet Infect Dis 2013;13(4):313-318.
30. Blower SM, Gershengorn HB, and Grant RM: A tale of two futures: HIV and antiretroviral therapy in San Francisco. Science 2000;287(5453):650-654.
31. Velasco-Hernandez JX, Gershengorn HB, and Blower SM: Could widespread use of combination antiretroviral therapy eradicate HIV epidemics? Lancet Infect Dis 2002;2(8): 487-493.
32. Granich RM, Gilks CF, Dye C, et al.: Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: A mathematical model. Lancet 2009;373(9657):48-57.
33. Xiridou M, Geskus R, de Wit J, et al.: Primary HIV infection as source of HIV transmission within steady and casual partnerships among homosexual men. AIDS 2004;18(9):1311-1320.
34. Delva W, Wilson DP, Abu-Raddad L, et al.: HIV treatment as prevention: Principles of good HIV epidemiology modelling for public health decision-making in all modes of prevention and evaluation. PLoS Med 2012;9(7):e1001239.
35. Cohen MS, Chen YQ, McCauley M, et al.: Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011;365(6):493-505.
36. Jia Z, Mao Y, Zhang F, et al.: Antiretroviral therapy to prevent HIV transmission in serodiscordant couples in China (2003-2011): A national observational cohort study. Lancet 2013;382(9899):1195-1203.
37. He N, Duan S, Ding Y, et al.: Antiretroviral therapy reduces HIV transmission in discordant couples in rural Yunnan, China. PloS One 2013;8(11):e77981.
38. Donnell D, Baeten JM, Kiarie J, et al.: Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: A prospective cohort analysis. Lancet 2010;375(9731):2092-2098.
39. Wilson DP: Evidence is still required for treatment as prevention for riskier routes of HIV transmission [letter]. AIDS 2010;24(18):2891-2892.
40. Muessig KE, Smith MK, Powers KA, et al.: Does ART prevent HIV transmission among MSM? AIDS 2012;26: 2267-2273.
41. Centers for Disease Control and Prevention: Today's HIV epidemic. www.cdc.gov/nchhstp/newsroom/docs/HIVFact-Sheets/TodaysEpidemic-508.pdf. Accessed July 16, 2013.
42. Kranzer K, Lawn SD, Johnson LF, et al.: Community viral load and CD4 count distribution among people living with HIV in a South African township: Implications for treatment as prevention. J Acquir Immune Defic Syndr 2013;63: 498-505.
43. Hallett TB and Eaton JW: A side door into care cascade for HIV-infected patients? J Acquir Immune Defic Syndr 2013; 63(Suppl 2):S228-S232.
44. May RM and Anderson RM: Transmission dynamics of HIV infection. Nature 1987;326(6109):137-142.
45. Garnett GP: The basic reproductive rate of infection and the course of HIV epidemics. AIDS Patient Care STDS 1998; 12(6):435-449.
46. Kretzschmar M and Carael M: Is concurrency driving HIV transmission in sub-Saharan African sexual networks? The significance of sexual partnership typology. AIDS Behav 2012;16(7):1746-1752.
47. Kretzschmar M, van der Loeff M, Birrell P, et al.: Prospects of elimination of HIV with test-and-treat strategy. Proc Natl Acad Sci USA 2013;110(39):15538-15543.
48. Hue S, Clewley JP, Cane PA, et al.: HIV-1 pol gene variation is sufficient for reconstruction of transmissions in the era of antiretroviral therapy. AIDS 2004;18:719-728.
49. Volz EM, Koopman JS, Ward MJ, et al.: Simple epidemiological dynamics explain phylogenetic clustering of HIV from patients with recent infection. PLoS Comput Biol 2012;8(6):e1002552.
50. Aldous JL, Pond SK, Poon A, et al.: Characterizing HIV transmission networks across the United States. Clin Infect Dis 2012;55(8):1135-1143.
51. Stadler T and Bonhoeffer S: Uncovering epidemiological dynamics in heterogeneous host populations using phylogenetic methods. Philos Trans R Soc Lond B Biol Sci 2013;368:20120198.
52. Brenner B, Wainberg MA, and Roger M: Phylogenetic inferences on HIV-1 transmission: Implications for the design of prevention and treatment interventions. AIDS 2013;27(7):1045-1057.
53. Stadler T, Kouyos R, von Wyl V, et al.: Estimating the basic reproductive number from viral sequence data. Mol Biol Evol 2012;29(1):347-357.
54. Volz EM, Koelle K, and Bedford T: Viral phylodynamics. PLoS Comput Biol 2013;9(3):e1002947.
55. Global Commission on HIV and the Law: Global Commission on HIV and the Law: Rights, Risk, Health. www.hivlawcommission.org/resources/report/ FinalReport-Risks, Rights&Health-EN.pdf. Accessed July 15, 2013.
56. Bernard E, Azad Y, Vandamme A, et al.: The use of phylogenetic analysis as evidence in criminal investigation of HIV transmission. www.nat.org.uk/ Media%20library/Files/PDF%20Documents/HIV-Forensics.pdf. Accessed October 21, 2013.
57. Smith KP and Christakis NA: Social networks and health. Annu Rev Sociol 2008;34:405-429.
58. Helleringer S, Mkandawire J, Kalilani-Phiri L, et al.: Cohort profile: The Likoma Network Study (LNS). Int J Epidemiol 2013; [Epub ahead of print]; DOI:10.1093/ije/dyt001.
59. Hoots BE, MacDonald PDM, Hightow-Weidman LB, et al.: Developing a predictive model to prioritize human immunodeficiency virus partner notification in North Carolina. Sex Transm Dis 2012;39(1):65-71.
60. Salganik MJ and Heckathorn DD: Sampling and estimation in hidden populations using respondent-driven sampling. Sociol Methodol 2004;34:193-239.
61. Kimbrough LW, Fisher HE, Jones KT, et al.: Accessing social networks with high rates of undiagnosed HIV infection: The Social Networks Demonstration Project. Am J Public Health 2009;99(6):1093-1099.
62. Bengtsson L, Lu X, Nguyen QC, et al.: Implementation of web-based respondent-driven sampling among men who have sex with men in Vietnam. PLoS One 2012; 7:e49417.
63. McCoy SI, Shiu K, Martz TE, et al.: Improving the efficiency of HIV testing with peer recruitment, financial incentives, and the involvement of persons living with HIV infection. J Acquir Immune Defic Syndr 2013;63(2):e56-e63.
64. Lu X, Bengtsson L, Britton T, et al.: The sensitivity of respondent-driven sampling. J R Stat Soc Ser A Stat Soc 2012;175:191-216.
65. van Sighem A, Jansen I, Bezemer D, et al.: Increasing sexual risk behaviour among Dutch men who have sex with men: Mathematical models versus prospective cohort data. AIDS 2012;26(14):1840-1843.
66. Fisher M, Pao D, Brown AE, et al.: Determinants of HIV-1 transmission in men who have sex with men: A combined clinical, epidemiological and phylogenetic approach. AIDS 2010;24(11):1739-1747.
67. Grabowski MK, Lessler J, Redd AD, et al.: Frequent viral introductions sustain local HIV epidemics in rural Rakai, Uganda. Paper presented at the 20th Conference on Retroviruses and Opportunistic Infections, Atlanta, Georgia, 2013.
68. Rocha LE and Blondel VD: Bursts of vertex activation and epidemics in evolving networks. PLoS Comput Biol 2013; 9:e1002974.
69. Romero-Severson E, Alam S, Volz E, et al.: Heterogeneity in number and type of sexual contacts in a gay urban cohort. Stat Commun Infect Dis 2012;4(4):1-18.
70. Gwadz M: Peer-driven intervention to seek, test and treat heterosexuals at high risk for HIV. www.cduhr.org/projects/description.aspx?projectID=72. Accessed June 6, 2013.
71. Jenness SM, Neaigus A, Murrill CS, et al.: Estimated HIV incidence among high-risk heterosexuals in New York City, 2007. J Acquir Immune Defic Syndr 2011;56(2):193-197.
72. Truong H: HIV transmission cluster analysis to inform prevention. http://projectreporter.nih.gov/project-info-description.cfm?aid= 8263303&icde=16571418&ddparam=&ddvalue=&ddsub=&cr =1&csb=default&cs=ASC. Accessed June 6, 2013.
73. Remien R: Structural intervention to increase screening and testing for acute HIV infection. http://projectreporter.nih.gov/project-info-description. cfm?aid=8434183&icde=16568781 &ddparam=&ddvalue=&ddsub=&cr= 3&csb=default&cs=ASC. Accessed June 6, 2013.
74. Pilcher C, Louie B, Facente S, et al.: Performance of rapid point-of-care and laboratory tests for acute and established HIV infection in San Francisco. PloS One 2013;8(12): e80629.
75. Christopoulos KA, Zetola NM, Klausner JD, et al.: Leveraging a rapid, round-the-clock HIV testing system to screen for acute HIV infection in a large urban public medical center. J Acquir Immune Defic Syndr 2012;62: e30-e38.
76. Hightow-Weidman LB, Fowler B, Kibe J, et al.: HealthMpowerment.org: Development of a theory-based HIV/STI website for young black MSM. AIDS Educ Prev 2011;23(1):1-12.
77. Hightow-Weidman LB, Pike E, Fowler B, et al.: HealthMpowerment.org: Feasibility and acceptability of delivering an Internet intervention to young black men who have sex with men. AIDS Care 2012;24(7):910-920.
78. Muessig KE, Pike EC, LeGrand S, et al.: Mobile phone applications for the care and prevention of HIV and other sexually transmitted diseases: A review. J Med Internet Res 2013;15(1):19-40.
79. Case KK, Ghys PD, Gouws E, et al.: Understanding the modes of transmission model of new HIV infection and its use in prevention planning. Bull World Health Organ 2012;90:831a-838a.
80. Lucas A and Armbruster B: The cost-effectiveness of expanded HIV screening in the United States. AIDS 2012; 27:795-801.
81. van Rooyen H, Barnabas RV, Baeten JM, et al.: High HIV testing uptake and linkage to care in a novel program of home-based HIV counseling and testing with facilitated referral in KwaZulu-Natal, South Africa. J Acquir Immune Defic Syndr 2013;64(1):e1-e8.
82. Jani IV, Sitoe NE, Alfai ER, et al.: Effect of point-of-care CD4 cell count tests on retention of patients and rates of antiretroviral therapy initiation in primary health clinics: An observational cohort study. Lancet 2011;378(9802): 1572-1579.
83. Jani I, Meggi B, Vubil A, et al.: Evaluation of point-of-care nucleic acid testing for HIV viral load and early infant diagnosis in primary health clinics: Mozambique. Paper presented at the 20th Conference on Retroviruses and Opportunistic Infections, Atlanta, Georgia, 2013.
84. Heffron R, Ngure K, Mugo N, et al.: Willingness of Kenyan HIV-1 serodiscordant couples to use antiretroviralbased HIV-1 prevention strategies. J Acquir Immune Defic Syndr 2012;61(1):116-119.
85. Hanna DB, Buchacz K, Gebo KA, et al.: Trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001-2009. Clin Infect Dis 2013;56(8):1174-1182.
86. Walker BD and Hirsch MS: Antiretroviral therapy in early HIV infection. N Engl J Med 2013;368(3):279-281.
87. Dolan P, Hallsworth M, Halpern D, et al.: Influencing behaviour: The mindspace way. J Econ Psychol 2012;33(1): 264-277.
88. Galarraga O, Genberg BL, Martin RA, et al.: Conditional economic incentives to improve HIV treatment adherence: Literature review and theoretical considerations. AIDS Behav 2013;17(7):2283-2292.
89. Marteau TM, Hollands GJ, and Fletcher PC: Changing human behavior to prevent disease: The importance of targeting automatic processes. Science 2012;337(6101): 1492-1495.